Khan Najat

CIK 00020209691 companySALT LAKE CITY, UT

SEC Profile

Transactions

Companies

Filings

CIK

0002020969

Recent Transactions

16 trades

Tax Payment
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-02-17$3.49/sh−14,280→ 2,290,383 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-02-06+1,673,546→ 2,284,681 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-02-06+30,346→ 2,315,027 total
Tax Payment
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-02-06$3.98/sh−10,364→ 2,304,663 total
Tax Payment
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-11-17$4.14/sh−17,584→ 735,538 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2025-11-05+169,851→ 169,851 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-11-05+84,925→ 753,122 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-08-18$5.52/sh−36,599→ 668,197 total
Tax Payment
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-08-15$5.64/sh−3,789→ 704,796 total
Tax Payment
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-05-15$4.25/sh−3,796→ 708,585 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2025-02-03+420,226→ 420,226 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-02-03+210,113→ 707,085 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-02-03+8,049→ 715,134 total
Tax Payment
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-02-03$7.25/sh−2,753→ 712,381 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-08-01+496,972→ 496,972 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2024-08-01+993,944→ 993,944 total

Companies

RECURSION PHARMACEUTICALS, INC.
Director, CEO and President
$RXRX

Recent Filings

Address

41 S. RIO GRANDE STREET

SALT LAKE CITY, UT, 84101

View on SEC.gov